Export 94 results:
Author Title Type [ Year
Filters: First Letter Of Title is M [Clear All Filters]
“MAS-1, a novel water-in-oil adjuvant/delivery system, with reduced seasonal influenza vaccine hemagglutinin dose may enhance potency, durability and cross-reactivity of antibody responses in the elderly.”, Vaccine, vol. 40, no. 10, pp. 1472-1482, 2022.
, “Maternal body composition and gestational weight gain in relation to asthma control during pregnancy.”, PLoS One, vol. 17, no. 4, p. e0267122, 2022.
, “Macular Telangiectasia Type 2: Visual Acuity, Disease End Stage, and the MacTel Area: MacTel Project Report Number 8.”, Ophthalmology, 2020.
, “Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations.”, Contemp Clin Trials, vol. 93, p. 106014, 2020.
, “Moving Forward in Cervical Cancer - Enhancing Susceptibility to DNA Repair Inhibition and Damage: NCI Clinical Trials Planning Meeting Report.”, J Natl Cancer Inst, 2020.
, “An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.”, N Engl J Med, 2020.
, “Measuring IRB Regulatory Compliance: Development, Testing, and Use of the National Cancer Institute StART Tool.”, J Empir Res Hum Res Ethics, vol. 14, no. 2, pp. 95-106, 2019.
, “Measuring the impact of a mandatory province-wide vaccinate-or-mask policy on healthcare worker absenteeism in British Columbia, Canada.”, Vaccine, vol. 37, no. 30, pp. 4008-4014, 2019.
, “Measuring the impact of influenza vaccination on healthcare worker absenteeism in the context of a province-wide mandatory vaccinate-or-mask policy.”, Vaccine, vol. 37, no. 30, pp. 4001-4007, 2019.
, “Month 12 Outcomes After Treatment Change at Month 6 Among Poor Responders to Aflibercept or Bevacizumab in Eyes With Macular Edema Secondary to Central or Hemiretinal Vein Occlusion: A Secondary Analysis of the SCORE2 Study.”, JAMA Ophthalmol, vol. 137, no. 3, pp. 281-287, 2019.
, , “Multicenter, randomized, double-blind, placebo-controlled clinical trial of vital wheat gluten oral immunotherapy.”, J Allergy Clin Immunol, vol. 143, no. 2, pp. 651-661.e9, 2019.
, “Mupirocin for Decolonization of Infants in Neonatal Intensive Care Units.”, Pediatrics, vol. 143, no. 1, 2019.
, “Monitoring Serious Adverse Events in the Sierra Leone Trial to Introduce a Vaccine Against Ebola.”, J Infect Dis, vol. 217, no. suppl_1, pp. S24-S32, 2018.
, “The Medication Level Variability Index (MLVI) Predicts Poor Liver Transplant Outcomes: A Prospective Multi-Site Study.”, Am J Transplant, vol. 17, no. 10, pp. 2668-2678, 2017.
, “Microscopic Analysis and Quality Assessment of Induced Sputum From Children With Pneumonia in the PERCH Study.”, Clin Infect Dis, vol. 64, no. suppl_3, pp. S271-S279, 2017.
, “Molecular Evolution of Herpes Simplex Virus 2 Complete Genomes: Comparison between Primary and Recurrent Infections.”, J Virol, vol. 91, no. 23, 2017.
, “Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.”, J Clin Oncol, vol. 35, no. 11, pp. 1154-1161, 2017.
, “Maximizing Effectiveness Trials in PTSD and SUD Through Secondary Analysis: Benefits and Limitations Using the National Institute on Drug Abuse Clinical Trials Network "Women and Trauma" Study as a Case Example.”, J Subst Abuse Treat, vol. 56, pp. 23-33, 2015.
, “Maximizing Effectiveness Trials in PTSD and SUD Through Secondary Analysis: Benefits and Limitations Using the National Institute on Drug Abuse Clinical Trials Network "Women and Trauma" Study as a Case Example”, J Subst Abuse Treat, vol. 56, pp. 23-33, 2015.
, “Multimodal Imaging in Type 2 Idiopathic Macular Telangiectasia”, Retina, vol. 35, pp. 742-749, 2015.
, “Multimodal imaging in type 2 idiopathic macular telangiectasia.”, Retina, vol. 35, no. 4, pp. 742-9, 2015.
, “Major Negative Social Impacts are Rare in Phase 1 HIV Vaccine Trials in Africa”, in HIV Research for Prevention 2014: AIDS Vaccine, Microbicide and ARV-based Prevention Science (HIVR4P), Cape Town, SA, 2014.
, “Mismatched related and unrelated donors for allogeneic hematopoietic cell transplantation for adults with hematologic malignancies.”, Biol Blood Marrow Transplant, vol. 20, no. 10, pp. 1485-92, 2014.
, “Mismatched Related and Unrelated Donors for Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancies”, Biol Blood Marrow Transplant, vol. 20, pp. 1485-1492, 2014.
,